RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+10.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$630M
AUM Growth
+$630M
(+12%)
Cap. Flow
+$14.3M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
120
New
23
Increased
22
Reduced
39
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 2 |
Merck
MRK
|
$12.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$12.4M |
| 4 |
AGN
Allergan plc
AGN
|
$6.33M |
| 5 |
UnitedHealth
UNH
|
$6.3M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$20M |
| 2 |
Pfizer
PFE
|
$13.2M |
| 3 |
Medtronic
MDT
|
$11M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$8.04M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
$8M |
Sector Composition
| 1 | Healthcare | 86.01% |
| 2 | Financials | 0.83% |
| 3 | Technology | 0.09% |
| 4 | Energy | 0.06% |
| 5 | Industrials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Labcorp
LH
$22.8B
| $4.12M | 0.66% |
30,000
-15,000
| -33% | -$2.06M |
|
|
RDUS
52
DELISTED
Radius Health, Inc.
RDUS
| $4.06M | 0.64% |
75,000
-25,000
| -25% | -$1.35M |
|
53
Thermo Fisher Scientific
TMO
$183B
| $3.98M | 0.63% |
+25,000
| New | +$3.98M |
|
|
CEMP
54
DELISTED
Cempra, Inc.
CEMP
| $3.9M | 0.62% |
161,000
-10,000
| -6% | -$242K |
|
|
ARRY
55
DELISTED
Array Biopharma Inc
ARRY
| $3.71M | 0.59% |
550,000
+180,000
| +49% | +$1.22M |
|
56
Universal Health Services
UHS
$11.6B
| $3.7M | 0.59% |
+30,000
| New | +$3.7M |
|
57
DaVita
DVA
$9.72B
| $3.63M | 0.58% |
+55,000
| New | +$3.63M |
|
|
NXTM
58
DELISTED
NxStage Medical Inc.
NXTM
| $3.63M | 0.58% |
145,300
| – | – |
|
59
Cooper Companies
COO
$13.3B
| $3.59M | 0.57% |
20,000
-5,000
| -20% | -$896K |
|
60
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $3.52M | 0.56% |
131,357
| – | – |
|
|
RVNC
61
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.4M | 0.54% |
210,000
-10,000
| -5% | -$162K |
|
62
Perrigo
PRGO
$3.21B
| $3.23M | 0.51% |
35,000
+15,000
| +75% | +$1.38M |
|
63
Dynavax Technologies
DVAX
$1.19B
| $3.15M | 0.5% |
300,000
+150,000
| +100% | +$1.57M |
|
|
CMRX
64
DELISTED
Chimerix, Inc.
CMRX
| $3.05M | 0.48% |
550,000
| – | – |
|
65
Halozyme
HALO
$8.75B
| $3.02M | 0.48% |
250,000
| – | – |
|
|
PTLA
66
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.74M | 0.44% |
120,805
+15,805
| +15% | +$359K |
|
|
NDRM
67
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $2.67M | 0.42% |
144,546
| – | – |
|
|
KERX
68
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $2.66M | 0.42% |
500,111
+50,000
| +11% | +$266K |
|
69
Insulet
PODD
$24.2B
| $2.33M | 0.37% |
57,000
-25,000
| -30% | -$1.02M |
|
|
RAD
70
DELISTED
Rite Aid Corporation
RAD
| $2.31M | 0.37% |
+300,000
| New | +$2.31M |
|
|
TSRO
71
DELISTED
TESARO, Inc.
TSRO
| $2.16M | 0.34% |
+21,500
| New | +$2.16M |
|
|
ACHN
72
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.15M | 0.34% |
266,000
| – | – |
|
73
FibroGen
FGEN
$48.4M
| $2.15M | 0.34% |
104,000
-10,000
| -9% | -$207K |
|
|
ADMS
74
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $2.13M | 0.34% |
130,000
| – | – |
|
|
ITCI
75
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.06M | 0.33% |
135,000
+20,000
| +17% | +$305K |
|